Xcede Technologies’ Announces Favorable Results from ISO 10993-1 Biological Evaluation of Medical Devices – Part 1 Studies

Seattle, WA.  Oct 3, 2017 – Xcede Technologies announced today that they have completed the bulk of the required ISO 10993-1 Testing Program for the Xcede Hemostatic Patch.  These studies are based on the international standard for medical devices that come into direct or indirect contact with the human body in order to determine the potential for an unacceptable adverse… Read more »